| J3262 | Injection, tocilizumab, 1 mg | 49,370 | $10 | $246.8K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 6,530 | $30 | $221.8K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 17,550 | $10 | $193.1K |
| J0897 | Injection, denosumab, 1 mg | 5,460 | $20 | $98.3K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3,130 | $30 | $81.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 390 | $80 | $32.1K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 320 | $90 | $27.5K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 110 | $120 | $13K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 1,120 | $1 | $4.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 70 | $60 | $4K |